Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. company information, Employees & Contact Information

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS). PoNS®, short for Portable Neuromodulation Stimulator, is an innovative medical device. It is inclusive of a controller and mouthpiece, that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control balance and gait. PoNS is meant to be used in conjunction with supervised therapeutic activity, referred to as, PoNS Therapy®. Use of the device while engaging in movement and coordination tasks promotes neuromodulation, activating brain pathways to help improve balance and gait. PoNS is authorized in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. PoNS is authorized in Canada for three indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (ii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke, to be used in conjunction with physical therapy. PoNS is authorized in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait.

Company Details

Employees
31
Address
642 Newtown Yardley Road,
Phone
(215) 809-2018
Industry
Medical Device
Keywords
IT Consulting.
HQ
Newtown, Pennsylvania
Looking for a particular Helius Medical Technologies, Inc. employee's phone or email?

Helius Medical Technologies, Inc. Questions

News

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements - GlobeNewswire

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements GlobeNewswire

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering - Yahoo Finance

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering Yahoo Finance

Helius Medical Technologies Achieves Compliance with Nasdaq Listing Requirements - Nasdaq

Helius Medical Technologies Achieves Compliance with Nasdaq Listing Requirements Nasdaq

Helius Medical Technologies, Inc. Announces Acquisition of Solana Tokens as Part of Digital Asset Treasury Strategy - Quiver Quantitative

Helius Medical Technologies, Inc. Announces Acquisition of Solana Tokens as Part of Digital Asset Treasury Strategy Quiver Quantitative

Cigna Becomes 5th Major Insurer to Cover Helius Medical's $19K Neural Device - Major Reimbursement Milestone - Stock Titan

Cigna Becomes 5th Major Insurer to Cover Helius Medical's $19K Neural Device - Major Reimbursement Milestone Stock Titan

Helius Medical Technologies Announces Reverse Stock Split - GlobeNewswire

Helius Medical Technologies Announces Reverse Stock Split GlobeNewswire

Just Confirmed: Helius Medical Secures Complete Nasdaq Compliance, Clearing Both Equity and Price Requirements - Stock Titan

Just Confirmed: Helius Medical Secures Complete Nasdaq Compliance, Clearing Both Equity and Price Requirements Stock Titan

Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire

Helius Medical Technologies, Inc. Announces Reimbursement GlobeNewswire

Major Breakthrough: Aetna Becomes Third Insurance Giant to Cover Helius Medical's MS Treatment Device - Stock Titan

Major Breakthrough: Aetna Becomes Third Insurance Giant to Cover Helius Medical's MS Treatment Device Stock Titan

Helius Medical Technologies, Inc. Announces Claim - GlobeNewswire

Helius Medical Technologies, Inc. Announces Claim GlobeNewswire

Helius Medical's 1-for-50 Reverse Split Slashes Outstanding Shares from 33.8M to 0.7M - Stock Titan

Helius Medical's 1-for-50 Reverse Split Slashes Outstanding Shares from 33.8M to 0.7M Stock Titan

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewswire

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device GlobeNewswire

Helius Medical's 1:15 Reverse Split Aims to Meet Nasdaq Requirements: What Shareholders Must Know - Stock Titan

Helius Medical's 1:15 Reverse Split Aims to Meet Nasdaq Requirements: What Shareholders Must Know Stock Titan

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria - GlobeNewswire

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria GlobeNewswire

Helius Medical Technologies, Inc. Announces Exercise of - GlobeNewswire

Helius Medical Technologies, Inc. Announces Exercise of GlobeNewswire

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target - GlobeNewswire

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target GlobeNewswire

Helius Medical Technologies, Inc. Announces First Clinical - GlobeNewswire

Helius Medical Technologies, Inc. Announces First Clinical GlobeNewswire

Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke - GlobeNewswire

Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke GlobeNewswire

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation - GlobeNewswire

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation GlobeNewswire

Helius Medical Technologies Receives Confirmation of Nasdaq Compliance for Minimum Bid Price Requirement - Nasdaq

Helius Medical Technologies Receives Confirmation of Nasdaq Compliance for Minimum Bid Price Requirement Nasdaq

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company - PR Newswire

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company PR Newswire

Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain - GlobeNewswire

Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain GlobeNewswire

Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings - Business Wire

Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings Business Wire

Helius Medical Secures $9.1M Financing: Complex Warrant Structure Offers Unique Investment Opportunity - Stock Titan

Helius Medical Secures $9.1M Financing: Complex Warrant Structure Offers Unique Investment Opportunity Stock Titan

$1.25B Potential Raise: Helius Launches First Major SOL Treasury Vehicle with Pantera Capital Backing - Stock Titan

$1.25B Potential Raise: Helius Launches First Major SOL Treasury Vehicle with Pantera Capital Backing Stock Titan

$1.25B Potential Value: Helius Partners with Pantera to Launch Groundbreaking Solana Treasury Company - Stock Titan

$1.25B Potential Value: Helius Partners with Pantera to Launch Groundbreaking Solana Treasury Company Stock Titan

Revolutionary Stroke Treatment Proves Effective in Clinical Trials, Targets 7M Patient Market - Stock Titan

Revolutionary Stroke Treatment Proves Effective in Clinical Trials, Targets 7M Patient Market Stock Titan

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ - Stock Titan

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ Stock Titan

Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria - Stock Titan

Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria Stock Titan

Helius Medical Technologies Appoints Paul Buckman to its Board of Directors - citybiz

Helius Medical Technologies Appoints Paul Buckman to its Board of Directors citybiz

Helius Medical Technologies Appoints Dane C. Andreeff as CEO - citybiz

Helius Medical Technologies Appoints Dane C. Andreeff as CEO citybiz

Diversified Plastics, Inc. Manufactures Highly Complex, Close-Tolerance Plastic Parts for Helius Medical Technologies, Inc.'s PoNS™ device - 24-7 Press Release Newswire

Diversified Plastics, Inc. Manufactures Highly Complex, Close-Tolerance Plastic Parts for Helius Medical Technologies, Inc.'s PoNS™ device 24-7 Press Release Newswire

Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021 - Yahoo Lifestyle Australia

Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021 Yahoo Lifestyle Australia

Helius Medical Technologies Announces Clinical Device Readiness for PoNS - SEC.gov

Helius Medical Technologies Announces Clinical Device Readiness for PoNS SEC.gov

Top Helius Medical Technologies, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant